← Open Payments lookup

HASSAN ALMAAT: Open Payments

NPI 1467418467 · BLOOMFIELD HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,240 in 56 payments from 15 companies in 2025. Trend: 2023 $168 · 2024 $29 · 2025 $1,240

Food & beverage: $1,131Education: $109
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.14$320
Otsuka America Pharmaceutical, Inc.9$162
Lundbeck LLC7$140
Neurocrine BioSciences, Inc.4$104
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$102
E.R. Squibb & Sons, L.L.C.4$82
Alkermes, Inc.3$81
Corium, LLC2$60
Axsome Therapeutics, Inc.2$53
Janssen Pharmaceuticals, Inc2$47

Products named: REXULTI, AUSTEDO XR, INGREZZA, CAPLYTA, UZEDY, COBENFY, ARISTADA, Azstarys.

Industry payments across MI — which companies pay providers there.